CARA - Cara Therapeutics EPS beats by $0.01 beats on revenue May, 11 2020 04:04 PM Cara Therapeutics Inc. Cara Therapeutics (NASDAQ:CARA): Q1 GAAP EPS of -$0.62 beats by $0.01.Revenue of $8.1M (+84.1% Y/Y) beats by $3.39M.Press ReleaseMore news on: Cara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,